IND. SWIFT Fact Sheet, IND. SWIFT Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IND. SWIFT Fact Sheet    (ISWF)


Alert: Discover the Makings of Potential 'Crorepati' Stocks from Richa Agarwal


Here is the latest financial fact sheet of IND. SWIFT. For more details, see the IND. SWIFT quarterly results and IND. SWIFT share price and chart. For a sector overview, read our pharmaceuticals sector report.

IND. SWIFT Price History

Price Rs 11.0
Mkt Cap Rs m 595
Vol '000 7.1
P/E X -1.9
P/CF X 20.6
EPS (TTM) Rs -5.9
1 Day % 4.2
No. of shares m 54.16
1 Week % 23.6
1 Month % -8.1
1 Year % 100.4
52 week H/L Rs 18.8/4.7
As on May 20, 2022 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

IND. SWIFT Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
IND. SWIFT EQUITY SHARE DATA
High Rs8121165 
Low Rs45522 
Sales per share (Unadj.) Rs47.849.753.460.865.7 
Earnings per share (Unadj.) Rs-67.3-10.01.5-3.5-5.5 
Diluted earnings per shareRs-67.3-10.01.5-3.5-5.5 
Cash flow per share (Unadj.) Rs-60.7-3.67.82.70.5 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Avg Dividend yield %00000 
Book value per share (Unadj.) Rs-113.6-122.4-125.0-131.7-128.4 
Adj. book value per shareRs-113.6-122.4-124.9-131.7-128.3 
Shares outstanding (eoy) m54.1654.1654.1654.1654.16 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x0.10.20.10.10.1 
Avg P/E ratio x-0.1-0.95.3-1.1-0.6 
P/CF ratio (eoy) x-0.1-2.41.01.56.4 
Price / Book Value ratio x-0.1-0.1-0.100 
Dividend payout %00000 
Avg Mkt Cap Rs m312472433216184 
No. of employees `000NANANANANA 
Total wages/salary Rs m388447463489512 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
IND. SWIFT INCOME DATA
Net Sales Rs m2,5892,6912,8903,2953,561 
Other income Rs m13714684224152 
Total revenues Rs m2,7262,8362,9753,5193,713 
Gross profit Rs m-3,250-219375297402 
Depreciation Rs m357346340336327 
Interest Rs m16311538352522 
Profit before tax Rs m-3,634-53482-167-295 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m980253 
Profit after tax Rs m-3,643-54182-191-298 
Gross profit margin %-125.5-8.113.09.011.3 
Effective tax rate %-0.2-1.40-14.8-1.1 
Net profit margin %-140.7-20.12.8-5.8-8.4 
IND. SWIFT BALANCE SHEET DATA
Current assets Rs m2,0641,8611,9352,2862,652 
Current liabilities Rs m6,0785,9826,1596,5417,062 
Net working cap to sales %-155.0-153.2-146.1-129.1-123.9 
Current ratio x0.30.30.30.30.4 
Inventory Days Days160160144114153 
Debtors Days Days1,5291,1339541,0431,107 
Net fixed assets Rs m4,5814,2864,0493,7304,064 
Share capital Rs m250250108108108 
"Free" reserves Rs m-6,405-6,882-6,876-7,240-7,060 
Net worth Rs m-6,155-6,632-6,767-7,131-6,952 
Long term debt Rs m6,6486,6706,4476,4426,442 
Total assets Rs m6,6466,1485,9846,0166,716 
Interest coverage x-21.3-3.73.20.50.4 
Debt to equity ratio x-1.1-1.0-1.0-0.9-0.9 
Sales to assets ratio x0.40.40.50.50.5 
Return on assets %-52.4-6.92.02.73.3 
Return on equity %59.28.2-1.22.74.3 
Return on capital %-704.4-1,098.1-37.3-26.9-44.5 
Exports to sales %45.958.769.569.574.2 
Imports to sales %3.66.13.24.15.0 
Exports (fob) Rs m1,1881,5802,0102,2902,643 
Imports (cif) Rs m9416593134176 
Fx inflow Rs m1,2071,6232,0342,3442,682 
Fx outflow Rs m104181137187260 
Net fx Rs m1,1031,4421,8972,1572,422 
IND. SWIFT CASH FLOW
From Operations Rs m -17 72 428 346 772 
From Investments Rs m 41 -64 -137 -114 -167 
From Financial Activity Rs m -107 -62 -130 -262 -483 
Net Cashflow Rs m -83 -54 160 -30 122 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 55.6%
Institution 0.0%
Non-Institution 44.4%
Total 100.0%
Free Float 44.4%
Pledged promoter holdings 73.4%
Shareholding as on Mar 2022
 

Company Information

Regd Off 781, Phase 2, Industrial Area, Chandigarh - 160002
E-mail info@indswift.com Web www.indswift.com
Tel +91-172-2638781-786 Fax +91-172-2652242
Sector PHARMACEUTICALS Group Private sector
Tr Agent Alankit Assignments Ltd., Alankit House 4 E/2, Jhandewala Extension
CHM: S R Mehta COMP SEC: Amrender Kumar Yadav YEAR OF INC: 1986 BSE CODE: 524652 FV (Rs): 2 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    LUPIN    

Compare IND. SWIFT With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    LUPIN    




Today's Market

4 Reasons Why Sensex Rallied 1,534 Points Today(0)

Bulls marked a strong comeback today as Indian share markets ended nearly 3% higher. After opening the day higher, equity markets extended gains as the session progressed and ended near the day's high.

Views on news

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

Nifty Pharma Index - Bulls are Losing the Ground (Views On News)

Mar 16, 2022

For the Nifty pharma index, it seems as if bulls are losing ground as they witness multiple bearish candlestick patterns.

IPO Alert! 3 Companies Including PharmEasy Get the Green Light (Views On News)

Feb 22, 2022

The strong momentum in India's IPO market is poised to continue with the market regulator approving the IPOs of three firms including PharmEasy.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far... (Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022 (Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022 (Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look... (Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better? (Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK IND. SWIFT

  • Track your investment in IND. SWIFT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON IND. SWIFT

IND. SWIFT 8-QTR ANALYSIS

COMPARE IND. SWIFT WITH

MARKET STATS